Nanofluidic Tools for Proteomic Sample Preparation

用于蛋白质组样品制备的纳米流体工具

基本信息

  • 批准号:
    7237946
  • 负责人:
  • 金额:
    $ 29.03万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-15 至 2009-06-30
  • 项目状态:
    已结题

项目摘要

Detailed proteomic analysis of biomolecule samples such as serum or cell extract could provide valuable information regarding the person's health or biological cells under study. However, current sample preparation technologies cannot deal with the diversity and dynamic range of these biomolecule samples effectively, and therefore the detection of information-rich minority protein species (signaling molecules and cytokines) is severely limited. Efficient protein separation in microfluidic systems could provide a solution for this challenge, but the limitation in sample volume, as well as the lack of molecular signal amplification strategy, has been major issues. Recent advances in nanofluidics provide useful tools for proteomic sample preparation, to address these challenges. Nanofluidic filters could be used for a gel-free separation of proteins based on the size. Permselective ion current generated by the nanofluidic channel was used to concentrate proteins and peptides from a dilute solution, to increase the sample volume capacity of the microfluidic sample preparation system. Also, continuous-flow pI-based biomolecule sorting system was demonstrated. In this project, we will develop these nanofluidic components further, and integrate them into an automatic proteomic sample preparation system that could sort out complex biomolecule sample based on the property of the target molecule. The flexibility and robustness of the micro/nanofluidic sample preparation devices that will be developed from this project will facilitate the system integration greatly. The resulting sample preparation microdevices could be easily integrated with various types of detectors, including antibody-based biosensor or mass spectrometry. Such an integration will enhance the selectivity and sensitivity of the biodetection by orders of magnitudes, therefore impacting various fields such as human health monitoring, biomarker detection, and systems biology.
对血清或细胞提取物等生物分子样本进行详细的蛋白质组学分析,可以提供有关研究对象健康状况或生物细胞的有价值信息。然而,目前的样品制备技术不能有效地处理这些生物分子样品的多样性和动态范围,因此,信息丰富的少数蛋白质种类(信号分子和细胞因子)的检测受到严重限制。微流控系统中的高效蛋白质分离可以为这一挑战提供解决方案,但样品体积的限制以及缺乏分子信号放大策略一直是主要问题。纳米流体技术的最新进展为蛋白质组样本制备提供了有用的工具,以解决这些挑战。纳米流体过滤器可用于基于大小的蛋白质的无凝胶分离。由纳米流体通道产生的选择性渗透离子电流用于从稀溶液中浓缩蛋白质和肽,以增加微流体样品制备系统的样品体积容量。此外,连续流PI为基础的生物分子分选系统进行了演示。在本项目中,我们将进一步开发这些纳米流体组件,并将其集成到自动蛋白质组样品制备系统中,该系统可以根据目标分子的特性分选复杂的生物分子样品。本计画所开发之微纳流体样品前处理装置,其灵活性与稳健性将极大地促进系统整合。由此产生的样品制备微器件可以很容易地与各种类型的检测器集成,包括基于抗体的生物传感器或质谱仪。这种整合将提高生物检测的选择性和灵敏度的数量级,因此影响各种领域,如人类健康监测,生物标志物检测和系统生物学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JONGYOON HAN其他文献

JONGYOON HAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JONGYOON HAN', 18)}}的其他基金

Continuous Production of Viral Vectors using membraneless Perfusion Culture of Host Cells
利用宿主细胞无膜灌注培养连续生产病毒载体
  • 批准号:
    10414312
  • 财政年份:
    2021
  • 资助金额:
    $ 29.03万
  • 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
  • 批准号:
    10201300
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
  • 批准号:
    10474343
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
Flexible Platform for End-to-end Manufacturing of Gene Therapies to Advance Development of Treatments for Ultra-rare Diseases
用于基因疗法端到端制造的灵活平台,以推进极罕见疾病治疗方法的开发
  • 批准号:
    10263273
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
Novel Process Analytic Technology for Continuous Bioprocessses
用于连续生物过程的新型过程分析技术
  • 批准号:
    9929893
  • 财政年份:
    2019
  • 资助金额:
    $ 29.03万
  • 项目类别:
Novel Process Analytic Technology for Continuous Bioprocessses
用于连续生物过程的新型过程分析技术
  • 批准号:
    10238815
  • 财政年份:
    2019
  • 资助金额:
    $ 29.03万
  • 项目类别:
Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH
极端 pH 条件下连续流动、不含两性电解质的基于 pI 的分选肽/蛋白质
  • 批准号:
    8010211
  • 财政年份:
    2010
  • 资助金额:
    $ 29.03万
  • 项目类别:
Continuous-flow, Ampholyte-free pI-based Sorting Peptides/proteins at Extreme pH
极端 pH 条件下连续流动、不含两性电解质的基于 pI 的分选肽/蛋白质
  • 批准号:
    7788037
  • 财政年份:
    2010
  • 资助金额:
    $ 29.03万
  • 项目类别:
PROJECT 10
项目10
  • 批准号:
    7695182
  • 财政年份:
    2008
  • 资助金额:
    $ 29.03万
  • 项目类别:
Nanofluidic Tools for Proteomic Sample Preparation
用于蛋白质组样品制备的纳米流体工具
  • 批准号:
    7121548
  • 财政年份:
    2005
  • 资助金额:
    $ 29.03万
  • 项目类别:

相似海外基金

Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 29.03万
  • 项目类别:
Computational modelling and simulation of antibodies to enhance binding affinity of a potential Burkholderia pseudomallei therapeutic
抗体的计算模型和模拟,以增强潜在的鼻疽伯克霍尔德氏菌治疗剂的结合亲和力
  • 批准号:
    2750554
  • 财政年份:
    2021
  • 资助金额:
    $ 29.03万
  • 项目类别:
    Studentship
Affinity Biosensors for COVID-19 Antibodies
适用于 COVID-19 抗体的亲和生物传感器
  • 批准号:
    61319
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
    Feasibility Studies
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10013588
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
Affinity maturation and property changes of single-domain antibodies through repeated immunizations.
通过重复免疫,单域抗体的亲和力成熟和性质变化。
  • 批准号:
    20K07009
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Rapid structure-based software to enhance antibody affinity and developability for high-throughput screening: Aiming toward total in silico design of antibodies
基于快速结构的软件可增强抗体亲和力和高通量筛选的可开发性:旨在实现抗体的全面计算机设计
  • 批准号:
    10603473
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
IN SILICO DESIGN OF HIGH-AFFINITY RECOMBINANT ANTIBODIES
高亲和力重组抗体的计算机模拟设计
  • 批准号:
    2342674
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
    Studentship
Strategies for generating high affinity antibodies against Gram negative bacteria
产生针对革兰氏阴性菌的高亲和力抗体的策略
  • 批准号:
    10117194
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
Directed Evolution of HIV Broadly Neutralizing Antibodies Using a Novel CRISPR-Engineered B cell in Vitro Affinity Maturation Platform
使用新型 CRISPR 工程 B 细胞在体外亲和力成熟平台定向进化 HIV 广泛中和抗体
  • 批准号:
    10115604
  • 财政年份:
    2020
  • 资助金额:
    $ 29.03万
  • 项目类别:
Interdisciplinary protein engineering approach to design high affinity antibodies for flaviviruses
跨学科蛋白质工程方法设计黄病毒高亲和力抗体
  • 批准号:
    10294224
  • 财政年份:
    2018
  • 资助金额:
    $ 29.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了